Fact Sheet: EtO Sterilization Prevents Infection
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
My Profile
Member Center
Policy
Top Priorities
On behalf of our members, AdvaMed works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
Your Featured Resources
AdvaMed Comment Letter to OIG – January 27, 2023
AdvaMed responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
Regulations and Reimbursement of Software as a Medical Device in Europe- Part1
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
Keeping Pace with Real-World Evidence: Evolving Software Regulations and the Growing Application of Artificial Intelligence
This white paper explores the increasing spotlight on the use of real world evidence, what regulators are looking for, and how AI-powered applications are rising in the field of digital…
Future of Medtech: Define New Markets Before They Define You
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.
The Digital Revenue Organization – A Post-Pandemic Perspective
Alexander Group surveyed digital, marketing, sales and service leaders across industries, and identified five key insights about the state of the Digital Revenue Organization post-pandemic.
Additional Resources
Fact Sheet: EtO Sterilization Prevents Infection
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
AdvaMed Comment Letter to OIG – January 27, 2023
AdvaMed responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
Regulations and Reimbursement of Software as a Medical Device in Europe- Part1
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
Keeping Pace with Real-World Evidence: Evolving Software Regulations and the Growing Application of Artificial Intelligence
This white paper explores the increasing spotlight on the use of real world evidence, what regulators are looking for, and how AI-powered applications are rising in the field of digital…
Discover More Resources
AdvaMed members have access to our full library of industry resources.
You are not logged in to the AdvaMed Hub.
QIAGEN CEO Thierry Bernard Named Chairman of AdvaMedDx Board of Directors
AdvaMedDx, a division of AdvaMed representing more than 75 manufacturers of innovative in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad, announced today that Thierry Bernard, CEO…
Johnson & Johnson EVP and Worldwide Chairman of Medtech Ashley McEvoy Named Chairman of AdvaMed Board of Directors
AdvaMed, the world’s leading medical technology association, announced that Ashley McEvoy, Executive Vice President and Worldwide Chairman of Medtech at Johnson & Johnson, was elected Chairman of the AdvaMed Board…
AdvaMed Commends Passage of EU MDR Changes to Ensure Continued Access to Lifesaving Treatments for European Patients
The European Union Council approved legislative changes to the Medical Device Regulation (EU MDR), finalizing a 3-4 ½ year extension on implementation of the new rules for certifying medical devices.…
AdvaMed Announces Medtech Industry’s “Medical Innovation Agenda for the 118th Congress”
AdvaMed, the largest global trade organization representing medical technology companies, released the medtech industry’s “Medical Innovation Agenda for the 118th Congress.” These policy priorities would advance AdvaMed’s goal to help…
AdvaMed’s Medical Innovation Agenda for the 118th Congress
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Automatic External Defibrillators (AEDs)
A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.
Terumo Blood and Cell Technologies’ IMUGARD Platelet Pooling Set Cleared by FDA
RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted the first marketing clearance for its SCINTIX™ biology-guided radiotherapy, a cutting-edge treatment applicable…
Women and Heart Disease
Heart attack symptoms in women can be different than in men and less well-known as heart attack-related. Women need their heart disease recognized and treated on equal footing with men.
Medical Technology Donations for the Turkish Earthquake Response
AdvaMed and its member companies are working with the U.S. government on medtech donations for humanitarian aid following the devastating earthquakes in southeast Turkey and northern Syria.
AdvaMed Statement on Biden’s Cancer Moonshot Commitment
The Advanced Medical Technology Association (AdvaMed), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from…
Membership Newsletter
We are pleased to provide AdvaMed members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.